90
|
Johns Hopkins HealthCare
o214 post transplantation high-dose cyclophosphamide treatment to promote immune tolerance after vascularized composite allotransplantation O214 Post Transplantation High Dose Cyclophosphamide Treatment To Promote Immune Tolerance After Vascularized Composite Allotransplantation, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/high+dose+immunizations/pm26573741-3056-0-33?v=Johns+Hopkins+HealthCare Average 90 stars, based on 1 article reviews
o214 post transplantation high-dose cyclophosphamide treatment to promote immune tolerance after vascularized composite allotransplantation - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |